Literature DB >> 19663711

Estimating survival in patients with cancer receiving palliative care: is analysis of body composition using bioimpedance helpful?

Gregory Brian Crawford1, Julie Ann Robinson, Roger Wayne Hunt, Neil Brenton Piller, Adrian Esterman.   

Abstract

BACKGROUND: This research investigated whether bioimpedance spectroscopy (BIS) has the potential to improve prognostication in an outpatient clinic for patients with cancer receiving palliative care.
METHODS: Survival time, and BIS measures of basal metabolic rate and 11 body composition parameters (extracellular fluid [ECF], intracellular fluid [ICF], ratio of ECF to ICF, fluid in trunk and each arm and leg, protein mass, mineral mass, and percent body fat) were recorded for 84 oncology patients.
RESULTS: None of the BIS measures showed a linear association with survival time. However, threshold values associated with short survival were identified for basal metabolic rate and 6 of the body composition measures related to fluid (ECF, ratio of ECF to ICF, fluid in right and left arms, and right and left legs). In addition, almost all patients who died within 6 weeks of assessment reached the threshold values for ECF and/or ECF:ICF ratio.
CONCLUSION: Results confirm that elevated metabolic rate and accumulation of body fluid are indicators of a poor prognosis in patients with cancer receiving palliative care. Because BIS is simple for clinicians to use, is noninvasive, and allows early detection of these parameters, it has the potential to improve prognostication.

Entities:  

Mesh:

Year:  2009        PMID: 19663711     DOI: 10.1089/jpm.2009.0093

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  3 in total

1.  Collapse of Fluid Balance and Association with Survival in Patients with Advanced Cancer Admitted to a Palliative Care Unit: Preliminary Findings.

Authors:  Koji Amano; Diane Liu; Eduardo Bruera; David Hui
Journal:  J Palliat Med       Date:  2019-10-29       Impact factor: 2.947

2.  Extracellular-to-Intracellular Fluid Volume Ratio as a Prognostic Factor for Survival in Patients With Metastatic Cancer.

Authors:  Jee Young Lee; Han Sung Ryu; Sung Soo Yoon; Eun Hye Kim; Seong Woo Yoon
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

3.  Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition.

Authors:  Paolo Cotogni; Taira Monge; Maurizio Fadda; Antonella De Francesco
Journal:  BMC Cancer       Date:  2018-10-17       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.